Inhibition of rat brain microsomal cytochrome P450-dependent dealkylation activities by an oxidative stress

Neurotoxicity Research

Volumn 3, Issue 4, 2001, Pages 359-368

  Lagrange, Philippe ^a,b   Dos Santos El Bachá, Ramon ^a,c   Netter, Patrick ^a   Minn, Alain ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Apomorphine; Cytochrome P450; Drug metabolism; Free radicals; Menadione; Protein oxidation

Indexed keywords

1,4 BENZOQUINONE; 2,4 DINITROPHENYLHYDRAZINE; APOMORPHINE; CARBONYL DERIVATIVE; CELL PROTEIN; CYTOCHROME P450; CYTOCHROME P450 1A1; ETHOXYRESORUFIN DEETHYLASE; LIPID; MENADIONE; NUCLEIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; BRAIN MICROSOME; CELL FUNCTION; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; ENZYME DENATURATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME MODIFICATION; ENZYME REGULATION; IMMUNOBLOTTING; MALE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; RECEPTOR AFFINITY;

EID: 0035160351     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033197     Document Type: Article

References (55)

1. Oxidants, antioxidants and the degenerative diseases of aging
2. Aging and proteolysis of oxidized proteins
3. A generalized increase in protein carbonyls in the brain in Parkinson's but not in incidental Lewy body disease
4. Oxidative modification of proteins during their turnover and phagocytosis
5. Is formation of reactive oxygen by cytochrome P450 perilous and predictable?
6. Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria
7. Evidence of an oxidative challenge in the Alzheimer's brain
8. Xenobiotic-mediated production of superoxide by primary cultures of rat cerebrovascular endothelial cells, astrocytes, and neurons
9. Aging, energy, and oxidative stress in neurodegenerative diseases
10. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species
11. Free radicals and neurodegeneration
12. Protein oxidation and aging. I. Difficulties in measuring reactive protein carbonyls in tissues using 2,4-dinitrophenylhydrazine
13. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenylnitrone
14. Drug metabolizing enzyme activities and superoxide formation in primary and immortalized rat brain endothelial cells
15. Regulation of gene expression by reactive oxygen
16. Protein damage and degradation by oxygen radicals. I. General aspects
17. Hypothesis: A damaging role in aging for reactive protein oxidation products
18. Toxic effects of apomorphine on rat C6 glial cells, and protection with antioxidants
19. Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain
20. Oxidative damage to behavior during aging
21. Inactivation of key metabolic enzymes by mixed-function oxidation reactions: Possible implication in protein turnover and ageing
22. NADPH:Cytochrome P-450 reductase: Biochemical characterization in rat brain and cultured neurons, and evolution of activity during development
23. Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs
24. Reactive oxygen species and the central nervous system
25. Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure
26. Oxidative mechanisms in nigral cell death in Parkinson's disease
27. Cerebral vessels in ageing and Alzheimer's disease
28. Heme and apoprotein modification of cytochrome P4502B4 during its oxidative inactivation in monooxygenase reconstituted system
29. Immunochemical detection of oxidized proteins
30. Superoxide anion production during monoelectronic reduction of xenobiotics by preparations of rat brain cortex, microvessels, and choroid plexus
31. Transendothelial permeability changes induced by free radicals in an in vitro model of the BBB
32. Contributory mechanism in the causation of neurodegenerative disorders
33. Superoxide production mediated by the redox cycling of xenobiotics in rat brain microsomes: Dependence on the reduction potentials
34. Protein measurement with the Folin phenol reagent
35. The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism
36. Redox cycling of radical anion metabolites of toxic chemicals and drugs and the Marcus theory of electron transfer
37. Drug-mediated inactivation of cytochrome P450
38. Protein oxidation in aging, disease and oxidative stress
39. Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions and cerebral microvessels
40. The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals
41. NADPH cytochrome P-450 reductase in rat, mouse and human brain
42. Xenobiotic metabolism in brain
43. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay
44. Superoxide dismutase and glutathione peroxidase activities in rat brain
45. Inactivation of mammalian brain glutamine synthetase by oxygen radicals
46. Oxidative stress and Parkinson's disease - Review
47. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease
48. Protein oxidation and aging
49. Protein oxidation and proteolysis during aging and oxidative stress
50. Enzymatic protection against peroxidative damage in isolated brain capillaries
51. Oxidative modification of cytochrome P450 durind its operation. I. Comparative investigation of the inactivation of cytochrome P450 LM2 in various system
52. Cimetidine neurotoxicity. EEG and behaviour aspects
53. Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions
54. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?